@prefix dcterms: .
@prefix this: .
@prefix sub: .
@prefix beldoc: .
@prefix rdfs: .
@prefix rdf: .
@prefix xsd: .
@prefix dce: .
@prefix pav: .
@prefix np: .
@prefix belv: .
@prefix prov: .
@prefix Protein: .
@prefix mgi: .
@prefix geneProductOf: .
@prefix sdis: .
@prefix obo: .
@prefix occursIn: .
@prefix species: .
@prefix pubmed: .
@prefix orcid: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
sub:_1 geneProductOf: mgi:98926;
a Protein: .
sub:_2 occursIn: obo:CL_0000115, obo:UBERON_0000947, species:10090;
rdf:object sdis:monocyte%20adherence;
rdf:predicate belv:increases;
rdf:subject sub:_1;
a rdf:Statement .
sub:assertion rdfs:label "p(MGI:Vcam1) -> path(SDIS:\"monocyte adherence\")" .
}
sub:provenance {
beldoc: dce:description "Approximately 61,000 statements.";
dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
dce:title "BEL Framework Large Corpus Document";
pav:authoredBy sub:_4;
pav:version "20131211" .
sub:_3 prov:value "To indirectly examine the role of CS-1 FN in mediating monocyte adhesion to MAEC, we used a peptide that specifically blocks CS-1-mediated monocyte adhesion (43). This peptide blocks the LDV-binding site for CS-1 FN on VLA-4 (43). As shown in Fig. 14, monocyte adhesion to LOTG EC was decreased by 50% in the presence of the CS-1 FN blocking peptide. Use of a blocking antibody to VCAM-1 (44) also reduced adhesion by 30% (Fig. 14). Use of blocking antibodies to both 4 and 2 integrins (44) in monocytes completely prevented adhesion.";
prov:wasQuotedFrom pubmed:14676201 .
sub:_4 rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:14676201;
prov:wasDerivedFrom beldoc:, sub:_3 .
}
sub:pubinfo {
this: dcterms:created "2014-07-03T14:32:13.116+02:00"^^xsd:dateTime;
pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}